Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Chamath Palihapitiya is back with another SPAC. This time he's telling retail investors to stay away. Here's why.
Chamath Palihapitiya is back with a new SPAC. Many investors will remember past SPACs the investor was involved with and the po...
Venture capitalist Chamath Palihapitiya, once dubbed the "SPAC King," is returning to Wall Street with a new blank-chec...
UBS analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and lowers the price target from ...
Financial GuidanceFor full-year 2025, Clover Health is updating its guidance as follows:Current 2025 GuidancePrevious 2025 Guid...
Clover Health Investments (NASDAQ:CLOV) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimat...
